AR040287A1 - Plataforma para formulaciones transdermicas (pft) - Google Patents

Plataforma para formulaciones transdermicas (pft)

Info

Publication number
AR040287A1
AR040287A1 ARP030102324A ARP030102324A AR040287A1 AR 040287 A1 AR040287 A1 AR 040287A1 AR P030102324 A ARP030102324 A AR P030102324A AR P030102324 A ARP030102324 A AR P030102324A AR 040287 A1 AR040287 A1 AR 040287A1
Authority
AR
Argentina
Prior art keywords
platform
pft
transdermal formulations
active therapeutic
transdermal
Prior art date
Application number
ARP030102324A
Other languages
English (en)
Inventor
Yuval Simha Landschaft
Original Assignee
Holden Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Holden Dev Ltd filed Critical Holden Dev Ltd
Publication of AR040287A1 publication Critical patent/AR040287A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Abstract

Composición que se puede utilizar como plataforma para la administración por vía transdérmica de compuestos terapéuticos activos y/o nutrientes, que comprende (a) al menos un compuesto terapéutico activo y/o al menos un nutriente, y (b) una emulsión no oleaginosa.
ARP030102324A 2002-06-27 2003-06-27 Plataforma para formulaciones transdermicas (pft) AR040287A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10228680A DE10228680A1 (de) 2002-06-27 2002-06-27 Grundlage für transdermale Formulierungen (PTF)

Publications (1)

Publication Number Publication Date
AR040287A1 true AR040287A1 (es) 2005-03-23

Family

ID=29761469

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP030102324A AR040287A1 (es) 2002-06-27 2003-06-27 Plataforma para formulaciones transdermicas (pft)

Country Status (14)

Country Link
US (1) US20050118241A1 (es)
EP (1) EP1515706A2 (es)
JP (1) JP2005535635A (es)
KR (1) KR20050027995A (es)
CN (1) CN1665492A (es)
AR (1) AR040287A1 (es)
AU (1) AU2003252459A1 (es)
CA (1) CA2490022A1 (es)
DE (1) DE10228680A1 (es)
MX (1) MXPA04012732A (es)
MY (1) MY157852A (es)
TW (1) TW200500093A (es)
WO (1) WO2004002444A2 (es)
ZA (1) ZA200500710B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7033998B2 (en) * 2003-04-11 2006-04-25 All Natural Fmg, Inc. Alcohol-free transdermal insulin composition and processes for manufacture and use thereof
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
US10042980B2 (en) 2005-11-17 2018-08-07 Gearbox Llc Providing assistance related to health
US10296720B2 (en) 2005-11-30 2019-05-21 Gearbox Llc Computational systems and methods related to nutraceuticals
US20110145009A1 (en) * 2005-11-30 2011-06-16 Jung Edward K Y Methods and systems related to transmission of nutraceutical associatd information
WO2010132562A2 (en) * 2009-05-12 2010-11-18 Ohio University Transdermal delivery of metformin
ES2693687T3 (es) * 2009-06-05 2018-12-13 Joan M. Caron Compuestos y composiciones para uso en el tratamiento del cáncer
EP3461338A1 (en) 2012-07-30 2019-04-03 Matinas BioPharma Nanotechnologies, Inc. Cochleates made with soy phosphatidylserine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4878892A (en) * 1987-02-10 1989-11-07 Drug Delivery Systems Inc. Electrolytic transdermal delivery of polypeptides
FR2616333A1 (fr) * 1987-06-12 1988-12-16 Cird Procede d'ionophorese pour administrer une substance dissoute ou partiellement dissoute, par voie percutanee ou perungueale et dispositif correspondant
JPS63316737A (ja) * 1987-06-19 1988-12-26 Toyo Jozo Co Ltd 経鼻投与用医薬組成物
IT1223343B (it) * 1987-11-03 1990-09-19 Also Lab Sas Formulazioni farmaceutiche per somministrazione transdermica
US5332577A (en) * 1988-12-27 1994-07-26 Dermamed Transdermal administration to humans and animals
EP0429842B1 (en) * 1989-10-27 1996-08-28 Korea Research Institute Of Chemical Technology Device for the transdermal administration of protein or peptide drug
US5073539A (en) * 1990-01-22 1991-12-17 Ciba-Geigy Corporation Transdermal administration of zwitterionic drugs
JPH06509577A (ja) * 1991-07-26 1994-10-27 スミスクライン・ビーチャム・コーポレイション Ｗ／ｏミクロエマルジョン
FR2687321B1 (fr) * 1992-02-14 1999-04-16 Elf Aquitaine Dispositif d'ionophorese pour l'administration transcutanee d'une quantite totale donnee d'un principe actif a un sujet.
WO1996010439A1 (fr) * 1994-09-30 1996-04-11 Kabushiki Kaisya Advance Interface pour administration iontophoretique transcutanee, et agent et methode de traitement de la peau a cette fin
US5707641A (en) * 1994-10-13 1998-01-13 Pharmaderm Research & Development Ltd. Formulations comprising therapeutically-active proteins or polypeptides
US5759445A (en) * 1995-05-24 1998-06-02 Matsushita Electric Industrial Co., Ltd. Lipid-dispersed solution and process for producing the same
US6183758B1 (en) * 1998-01-29 2001-02-06 Highland Laboratories, Inc. Phytochemicals, nutrients & medication absorption &/or treatment
ATE399565T1 (de) * 1998-07-07 2008-07-15 Transdermal Technologies Inc Zusammensetzungen für die schnelle und nicht- irritierende transdermale verabreichung von pharmazeutika and verfahren zur formuliering davon und ihren verabreichung
CA2369594A1 (en) * 1999-05-07 2000-11-16 Pharmasol Gmbh Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents

Also Published As

Publication number Publication date
CN1665492A (zh) 2005-09-07
AU2003252459A1 (en) 2004-01-19
WO2004002444A3 (en) 2004-03-11
JP2005535635A (ja) 2005-11-24
ZA200500710B (en) 2005-09-05
CA2490022A1 (en) 2004-01-08
TW200500093A (en) 2005-01-01
WO2004002444A2 (en) 2004-01-08
MXPA04012732A (es) 2005-11-17
US20050118241A1 (en) 2005-06-02
DE10228680A1 (de) 2004-01-22
EP1515706A2 (en) 2005-03-23
MY157852A (en) 2016-07-29
KR20050027995A (ko) 2005-03-21

Similar Documents

Publication Publication Date Title
ATE472551T1 (de) Tocopherolmodifizierte therapeutische arzneimittelverbindung
BR0312573A (pt) Derivados de fenil-[4-(3-fenil-1h-pirazol-4-il)-pirimidin-2-il]-amina
BRPI0506977A (pt) composto de tetrahidrocarbolina como agentes anticáncer
DOP2009000155A (es) Derivados de hetero-pentaciclo-fenilo fusionados, composicion farmaceutica que los comprende y usos para preparar un medicamento util para el tratamiento de una condicion mediada por p38
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
CY1111458T1 (el) Μορφες δοσολογιας γενικως γραμμικης, αναβραζουσας, απο του στοματος φεντανυλης και μεθοδοι χορηγησης
DE602006014990D1 (de) Intranasale verabreichung von schnell wirkendem insulin
AR047928A1 (es) Derivados de tetrahidropiridoindol
ATE410424T1 (de) Spirocyclische cyclohexan-derivate
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
BR0308613A (pt) Combinação de compostos orgânicos
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
AR109263A2 (es) Composición que comprende moxidectina
DE60134245D1 (de) (5-(2-hydroxy-4-chlorbenzoyl)valeriansäure und deren salze, und zusammensetzungen zur zuführung von wirkstoffen, die diese verbindungen enthalten
ECSP077387A (es) Composiciones que contienen piperacilina, tazobactam y un ácido aminocarboxílico en un diluyente de lactato de sodio
ATE548034T1 (de) Pharmazeutische zusammensetzungen mit droxidopa
BRPI0415953B8 (pt) formulação de dosagem de liberação controlada e conjunto de formas de dosagem de liberação controlada
AR040287A1 (es) Plataforma para formulaciones transdermicas (pft)
AR048672A1 (es) Tabletas de desintegracion que comprenden licarbazepina
ECSP045397A (es) 6-ALQUILIDEN-PENEMS BICÍCLICOS COMO INHIBIDORES DE LAS b-LACTAMASAS
BRPI0518554A2 (pt) uso de um inibidor de pde3
UY29561A1 (es) Derivados de quinazolina, composiciones farmacéuticas que los contienen, procedimientos de preparación y aplicaciones
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
ATE487492T1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
SE0302924D0 (sv) Pharmaceutical composition having a cationic excipient

Legal Events

Date Code Title Description
FA Abandonment or withdrawal